North America Veterinary Antimicrobial Susceptibility Testing Market Outlook 2025–2035
The North America Veterinary Antimicrobial Susceptibility Testing (AST) market provides solutions to gauge the effectiveness of antimicrobials against pathogens in animals, supporting responsible use of antibiotics in veterinary medicine. This sector incorporates both manual and automated testing methods, spanning disk diffusion, broth dilution, rapid and molecular tests, serving livestock, companion animals, aquaculture, and diagnostic and research laboratories. Growing concerns around antimicrobial resistance, stringent regulatory initiatives, and the adoption of technological advancements are driving market growth in the region. Leading players such as Thermo Fisher Scientific, BioMérieux, and BD offer a wide range of AST solutions utilizing genotypic and phenotypic methods, ensuring accuracy, speed, and improved workflow. As the market evolves, the integration of automation, digital data tracking, and point-of-care diagnostics are reshaping veterinary AST practices across North America.
Latest Market Dynamics
Key Drivers
- Rising Incidence of Antimicrobial Resistance (AMR): The increased prevalence of AMR in animal health is compelling veterinary practitioners to adopt advanced AST solutions. For instance, Thermo Fisher Scientific’s rapid AST platforms are seeing strong demand due to their ability to deliver quick and reliable results for both livestock and companion animals.
- Stringent Regulatory Guidelines: The implementation of stricter policies on antimicrobial usage in animals by government organizations such as the FDA is accelerating the adoption of AST. Companies like BioMérieux are working proactively to align products with these regulations, ensuring compliance and improved animal health outcomes.
Key Trends
- Automation in Susceptibility Testing: Automated AST platforms are streamlining laboratory workflows, reducing manual errors, and enabling high-throughput testing. BD’s Phoenix Automated Microbiology System reflects this trend by offering seamless integration into veterinary labs.
- Integration of Genotypic Testing: The use of molecular diagnostics for detecting resistance genes is gaining momentum, giving veterinarians deeper insights. Danaher Corporation’s recent genotypic AST kits exemplify this shift towards precision diagnostics.
Key Opportunities
- Expansion into Rapid and Point-of-Care Testing: There is significant market potential for rapid AST solutions enabling on-site decision-making. Neogen Corporation is capitalizing on this opportunity by unveiling rapid lateral flow tests tailored for field use.
- Emergence of Digital Data Platforms: Collaborative digital platforms that track AMR trends and share AST data across networks are in demand. Creative Diagnostics is enhancing its AST portfolio with digital data management capabilities, facilitating better surveillance.
Key Challenges
- High Cost of Advanced AST Systems: The adoption of highly automated, genotypic AST systems often requires substantial investment. Smaller clinics and diagnostic labs face budgetary constraints, even as product offerings from companies like Bruker expand.
- Limited Access to Skilled Personnel: Successfully operating advanced AST instruments still demands trained technicians. This shortage is especially acute in rural or underserved areas, impacting reliable adoption despite improved solutions from vendors like Mast Group Ltd.
Key Restraints
- Lack of Standardization: The absence of uniform protocols across veterinary AST testing introduces variability and impacts testing reliability. Even with regulatory guidance, harmonization remains a hurdle for suppliers such as Liofilchem.
- Complex Regulatory Approval Processes: Lengthy requirements for regulatory approval delay market entrance of innovative AST solutions, restraining the pace of product launches by companies like HiMedia Laboratories.
Market Share by Type in North America Veterinary Antimicrobial Susceptibility Testing, 2025
In 2025, Disk Diffusion remains the dominant testing type in the North America veterinary AST market, constituting the largest portion of market share. Automation and gradient diffusion techniques are experiencing a steady rise in adoption thanks to their precision and efficiency. However, traditional methods such as agar and broth dilution continue to be widely used, particularly in diagnostic labs and research institutions owing to their cost-effectiveness and familiarity. The market reflects a balanced blend of traditional and advanced AST methodologies as adoption of digital and automated solutions accelerates.
Market Share by Application in North America Veterinary AST Market, 2025
Livestock applications are projected to account for the largest share of the North American veterinary AST market in 2025, driven by high testing requirements in the food animal sector. Companion animals are the second-largest segment, fueled by rising pet ownership and intensifying focus on pet health. Aquaculture and diagnostic laboratory usage are steadily growing segments as well, benefiting from increased awareness and expanding regulatory oversight. This segmentation underscores the high utility and necessity of susceptibility testing across various animal health markets.
North America Veterinary Antimicrobial Susceptibility Testing Market Revenue (2020–2035)
The revenue of the North America veterinary AST market demonstrated a consistent upward trend from 2020 to 2035. In 2025, the market size is anticipated to reach 460 Million USD, reflecting robust growth propelled by expanding adoption of AST solutions across both clinical and field settings. Factors such as growing regulatory focus on antimicrobial stewardship, technological innovation in rapid and automated diagnostics, and increased incidence of zoonotic diseases are major contributors to this upward trajectory. The market is expected to continue its growth momentum through 2035.
Year-on-Year Growth (%) of North America Veterinary AST Market (2020–2035)
Year-on-year (YOY) growth rates in the North America veterinary AST market are projected to be strong throughout the forecast period. The market recorded impressive rise in 2025 at 8.1%, attributed mainly to technological advancements and regulatory momentum. Although YOY growth is expected to gradually moderate as the market matures, the sustained demand for antimicrobial stewardship and faster diagnostic solutions will support healthy growth rates till 2035.
Regional Share (%) in North America Veterinary AST Market, 2025
In 2025, the United States is predicted to claim the largest share of the North America veterinary AST market, thanks to advanced veterinary infrastructure, higher livestock population, and strict regulatory monitoring. Canada follows with steady market growth, while Mexico, although representing a smaller share, is witnessing rising investments and improved veterinary service capacity. The regional landscape is defined by high technological uptake in the US and growing awareness across Canada and Mexico.
Market Players’ Share (%) in North America Veterinary AST Market, 2025
Thermo Fisher Scientific and BioMérieux lead the North America veterinary AST market with their comprehensive and advanced product offerings. Becton Dickinson & Company and Neogen Corporation follow, expanding their portfolios through innovation in automated and rapid testing platforms. The top five players collectively hold the majority of market share, reinforcing market consolidation and strong competitive dynamics. Recognized brands continue to drive industry standards and technological progress.
Market Buyers’ Share (%) in North America Veterinary AST Market, 2025
Diagnostic laboratories represent the largest segment among buyers in North America's veterinary AST market, followed by veterinary clinics and large-scale livestock producers. These entities are integrating advanced susceptibility testing into routine diagnostics to ensure appropriate antimicrobial use. Increasing collaborations between laboratories and producers, as well as the growing presence of veterinary clinics in both urban and rural areas, are shaping the buyer landscape in 2025.
Study Coverage
| Metrics | Details |
|---|
| Years | 2020-2035 |
| Base Year | 2025 |
| Market Size | 460 |
| Regions | US, Canada, Mexico |
| Segments | Type (Disk Diffusion, Agar Dilution, Broth Dilution, Automated AST, Gradient Diffusion, Others), Application (Livestock, Companion Animals, Aquaculture, Research, Diagnostic Laboratories, Others), Distribution Channels (Direct Sales, Distributors, Online Sales, Retail Pharmacies, Veterinary Clinics, Others), Technology (Phenotypic, Genotypic, Automated Systems, Manual Testing, Rapid Testing, Others), Organization Size (Small, Medium, Large) |
| Players | Thermo Fisher Scientific, BioMérieux, Becton Dickinson & Company, Neogen Corporation, Danaher Corporation, Liofilchem, Creative Diagnostics, HiMedia Laboratories, Bioguard Corporation, Mast Group Ltd., Vetoquinol S.A., iNtRON Biotechnology Inc., Creative Diagnostics, Bruker Corporation, Alpha Labs |
Key Recent Developments
- June 2024: Thermo Fisher Scientific launched an upgraded Sensititre RAPID AST plate tailored to veterinary pathogen detection.
- July 2024: BioMérieux announced FDA compliance for its VITEK 2 AST system in veterinary use.
- August 2024: Neogen expanded its rapid on-farm AST testing portfolio with lateral flow cassettes for livestock applications.
- September 2024: Creative Diagnostics introduced a cloud-based data platform to enhance sharing of antimicrobial resistance insights.
- October 2024: BD deployed a new training program to address skilled labor shortages in veterinary AST across North America.
